News coverage about Walgreens Boots Alliance (NASDAQ:WBA) has trended somewhat positive on Saturday, Accern reports. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Walgreens Boots Alliance earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave news headlines about the pharmacy operator an impact score of 47.3144673126573 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
These are some of the headlines that may have effected Accern Sentiment’s scoring:
- $1.49 Earnings Per Share Expected for Walgreens Boots Alliance Inc (WBA) This Quarter (americanbankingnews.com)
- Walgreens Boots Alliance Inc (WBA) Sees Significant Decline in Short Interest (americanbankingnews.com)
- Rite Aid To Escalate ‘Wellness’ Focus For Stores In Albertsons Deal (finance.yahoo.com)
- Walgreens Boots Alliance Inc (WBA) to Issue $0.40 Quarterly Dividend (americanbankingnews.com)
- Rite Aid tops earnings estimates after completing sale of stores to Walgreens (finance.yahoo.com)
Shares of WBA stock traded down $0.22 during trading hours on Friday, reaching $63.82. 3,390,863 shares of the stock traded hands, compared to its average volume of 6,149,674. Walgreens Boots Alliance has a 1-year low of $61.74 and a 1-year high of $87.79. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.90 and a quick ratio of 0.45. The firm has a market capitalization of $63,506.27, a P/E ratio of 12.51, a P/E/G ratio of 1.03 and a beta of 1.16.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.55 by $0.18. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. The business had revenue of $33.02 billion for the quarter, compared to analyst estimates of $32.20 billion. During the same quarter in the previous year, the business earned $1.36 earnings per share. The firm’s revenue was up 12.1% compared to the same quarter last year. sell-side analysts predict that Walgreens Boots Alliance will post 5.95 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, May 17th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.51%. Walgreens Boots Alliance’s dividend payout ratio is currently 31.37%.
A number of analysts have recently weighed in on WBA shares. Needham & Company LLC reaffirmed a “buy” rating and issued a $88.00 price target (up from $86.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, January 10th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $85.00 price target for the company in a research note on Sunday, January 21st. ValuEngine raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research note on Thursday, January 4th. Robert W. Baird reaffirmed a “buy” rating and issued a $82.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, January 4th. Finally, Loop Capital set a $90.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Wednesday, January 3rd. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $83.20.
In other news, insider Stefano Pessina purchased 98,858 shares of the business’s stock in a transaction dated Monday, January 15th. The shares were acquired at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 14.80% of the stock is owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Walgreens Boots Alliance (WBA) Receiving Somewhat Positive News Coverage, Study Shows” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://ledgergazette.com/2018/04/14/walgreens-boots-alliance-wba-receiving-somewhat-positive-news-coverage-study-shows.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.